Tiny Nanoparticles Stop Metastasis in Mice

Posted by Kate Murphy on July 9th, 2008

Researchers at the University of California at San Diego targeted tumor blood vessels with chemotherapy carried by microscopic-sized nanoparticles. Although primary tumors were not affected, blood vessels were destroyed, keeping the tumors from spreading throughout the bodies of experimental mice.

The technique allows much lower doses of chemotherapy to be effective, eliminating toxic side effects and avoiding healthy tissue.

Mice with kidney and pancreatic cancers were treated with doxorubicin delivered by nanoparticles.  The particles honed in on cells that expressed a particular protein marker that is associated with blood vessels that feed cancerous tumors.

David Cheresh, Ph.D, Director of Translational Research at UCSD, said,

We were able to establish the desired anti-cancer effect while delivering the drug at levels 15 times below what is needed when the drug is used systemically. Even more interesting is that the metastatic lesions were more sensitive to this therapy than the primary tumor.

He continued,

Doxorubicin is known to be an effective anti-cancer drug, but has been difficult to give patients an adequate dose without negative side effects. This new strategy represents the first time we’ve seen such an impact on metastatic growth, and it was accomplished without the collateral damage of weight loss or other outward signs of toxicity in the patient.

SOURCE:  University of California San Diego News Release, July 7, 2008.

Eric A. Murphy et al, Proceedings of the National Academy of Sciences, Volume 105, Number 27, July 8, 2008.

Leave a Reply

Your comments are welcome. However, specific medical advice will not be provided, and we urge you to consult with a qualified physician for diagnosis and for answers to your personal questions. FightCRC is not responsible for the medical accuracy of any comments left by persons other than FightCRC staff members. FightCRC staff members monitor comments and may respond publicly where appropriate.

Please note that we automatically publish the name that you enter next to your post. Also note that our pages are automatically indexed by Google and other search engines, and your name may therefore appear in search results on those sites. So if you wish to remain anonymous please use a different name or enter 'Anon' as the name.

We regret that we are unable to privately answer questions left as comments. So please do not include your phone number, email or mailing address in the body of your comment. For the best personal and direct response to your colorectal cancer treatment questions, please call our Answer Line at 1-877-4CRC-111 (1-877-427-2111).

Please note that we automatically publish the name that you enter next to your post. Also note that our pages are automatically indexed by Google and other search engines, and your name may therefore appear in search results on those sites.